Rankings
▼
Calendar
NAGE Q1 2025 Earnings — Niagen Bioscience Inc Revenue & Financial Results | Market Cap Arena
NAGE
Niagen Bioscience Inc
$423M
Q1 2025 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$30M
+37.6% YoY
Gross Profit
$19M
63.4% margin
Operating Income
$5M
15.7% margin
Net Income
$5M
16.6% margin
EPS (Diluted)
$0.06
QoQ Revenue Growth
+4.7%
Cash Flow
Operating Cash Flow
$8M
Free Cash Flow
$8M
Stock-Based Comp.
$1M
Balance Sheet
Total Assets
$81M
Total Liabilities
$26M
Stockholders' Equity
$55M
Cash & Equivalents
$55M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$30M
$22M
+37.6%
Gross Profit
$19M
$13M
+43.7%
Operating Income
$5M
-$731,000
+752.8%
Net Income
$5M
-$492,000
+1129.1%
← FY 2025
All Quarters
Q2 2025 →